Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Alzheimer's Disease

  Free Subscription


16.02.2026

15 Alzheimers Dement
1 Am J Geriatr Psychiatry
1 Ann Neurol
1 BMJ
1 Curr Alzheimer Res
2 Exp Neurol
3 J Alzheimers Dis
2 J Neurochem
2 J Neurol
1 J Neurol Neurosurg Psychiatry
1 JAMA Intern Med
1 Nat Med
1 Neurobiol Dis
1 Neurochem Res
1 Neurology
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Alzheimers Dement

  1. WANG X, Bakulski KM, Walker E, Mukherjee B, et al
    Exposure to lead and incidence of Alzheimer's disease and all-cause dementia in the United States.
    Alzheimers Dement. 2026;22:e71075.
    PubMed         Abstract available

  2. LIU D, Jiang Z, Kim H, Tukker AM, et al
    From correlation to causation: cell-type-specific gene regulatory networks in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71053.
    PubMed         Abstract available

  3. JOBSON DD, Hase Y, Walker L, Polvikoski T, et al
    High vulnerability of medial prefrontal pyramidal neurons in post-stroke, vascular, Alzheimer's disease, and aging-related dementias.
    Alzheimers Dement. 2026;22:e71151.
    PubMed         Abstract available

  4. TSIKNIA AA, Terner JA, Tsokolas ZE, Shin DC, et al
    Cerebrovascular regulation dynamics and Alzheimer's neuroimaging phenotypes.
    Alzheimers Dement. 2026;22:e71146.
    PubMed         Abstract available

  5. CARY GA, Wiley JC, Carter GW, Levey AI, et al
    Beyond the streetlight: a TREAT-AD perspective on where to find new Alzheimer's targets.
    Alzheimers Dement. 2026;22:e71142.
    PubMed         Abstract available

  6. DUNLOP SR, Matchett BJ, Mannsbart AF, Al-Shaikh FSH, et al
    Greater locus coeruleus vulnerability in atypical clinicopathologic forms of Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71140.
    PubMed         Abstract available

  7. KELEMAN AA, Li M, Wisch JK, Bollinger RM, et al
    Falls predict faster progression to Alzheimer's dementia.
    Alzheimers Dement. 2026;22:e71177.
    PubMed         Abstract available

  8. YANG C, Timsina J, Liu M, Budde J, et al
    Analyses of plasma multi-omic data across ancestries identify novel pathways implicated in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71164.
    PubMed         Abstract available

  9. LI YJ, La JO, Naj A, Martin ER, et al
    Leveraging genetic propensity to identify modifiable factors for the age at onset of Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71111.
    PubMed         Abstract available

  10. CANOVAS R, Fowler CJ, Feizpour A, Dore V, et al
    Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectories.
    Alzheimers Dement. 2026;22:e71145.
    PubMed         Abstract available

  11. BRUGULAT-SERRAT A, Tsoy E, Sanchez-Benavides G, Mila-Aloma M, et al
    Detecting early memory changes in preclinical Alzheimer's disease using TabCAT favorites test: Data from the European Prevention of Alzheimer's Disease (EPAD) cohort.
    Alzheimers Dement. 2026;22:e71035.
    PubMed         Abstract available

  12. DE WAAL MWJ, van der Lee SJ, Lunding M, Boonkamp L, et al
    Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare SORL1 variants.
    Alzheimers Dement. 2026;22:e71042.
    PubMed         Abstract available

  13. SHISHEGAR R, Doecke JD, Lim YY, Bourgeat P, et al
    Harmonizing neuropsychological test data across prospective studies.
    Alzheimers Dement. 2026;22:e71186.
    PubMed         Abstract available

  14. YANG Y, Bhullar R, Conde S
    Spatial abilities in aging adults with Down syndrome.
    Alzheimers Dement. 2026;22:e71159.
    PubMed         Abstract available

  15. BOURGEAT P, Fripp J, Lebrat L, Xia Y, et al
    AI-enhanced Centiloid quantification of amyloid PET images.
    Alzheimers Dement. 2026;22:e71162.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  16. AW TBH, Leow YJ, Kandiah N
    Association of Plasma p-tau181 and Cognition in Nondemented Subjects Without Abeta(42/40) Positivity.
    Am J Geriatr Psychiatry. 2026;34:386-391.
    PubMed         Abstract available


    Ann Neurol

  17. B SZABO A, Curot J, Gerard F, Rulquin F, et al
    Refining Detection of Subclinical Epileptiform Activity in Alzheimer's Disease: A Case-Control Study and Call for a Consensus.
    Ann Neurol. 2026 Feb 11. doi: 10.1002/ana.78135.
    PubMed         Abstract available


    BMJ


  18. New treatments for Alzheimer's disease.
    BMJ. 2026;392:s273.
    PubMed        


    Curr Alzheimer Res

  19. BANIASADIPOUR B, Bagheri F, Hendudari F, Koopaee S, et al
    Molecular and Microstructural MRI of Neuroinflammation in Alzheimer's Disease.
    Curr Alzheimer Res. 2026 Feb 4. doi: 10.2174/0115672050420458251115070244.
    PubMed         Abstract available


    Exp Neurol

  20. FARKAS S, Jasper V, Nyers-Marosi K, Petrovai B, et al
    Targeting cholinergic cells in a mouse model of Alzheimer's disease: Validating a quadruple transgenic model.
    Exp Neurol. 2026;400:115684.
    PubMed         Abstract available

  21. WU L, Hou F, Wang Z, Wu M, et al
    Mitochondrial calcium uniporter knockdown in hippocampal neurons effectively attenuates synaptic plasticity impairment and pathology in APP/PS1/tau model of Alzheimer's disease.
    Exp Neurol. 2026 Feb 11:115686. doi: 10.1016/j.expneurol.2026.115686.
    PubMed         Abstract available


    J Alzheimers Dis

  22. ELUGBADEBO O, Farombi T, Arulogun O, Nichols M, et al
    Recruiting and retaining persons with suspected Alzheimer's disease and related dementias for genetic studies in selected African countries: Lived realities of researchers.
    J Alzheimers Dis. 2026 Feb 9:13872877261416066. doi: 10.1177/13872877261416066.
    PubMed         Abstract available

  23. ZHANG Y, Wang J, Yuan J, Li S, et al
    FA-2-b-beta modulates HMGB1/NF-kappaB/NLRP3 signaling to alleviate neuroinflammation in Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 10:13872877261418300. doi: 10.1177/13872877261418300.
    PubMed         Abstract available

  24. KUMAR GA, Pravallika P, Thirumalai V, Bukke SPN, et al
    Persicaria hydropiper attenuates oxidative stress and reactive oxygen species, and inhibits amyloid-beta/tau in SH-SY5Y cell lines via multiple pathways of Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 13:13872877261418555. doi: 10.1177/13872877261418555.
    PubMed         Abstract available


    J Neurochem

  25. BARAL R, van Deventer R, Lyubchenko YL
    Amyloid beta-Cholesterol Interplay: Removal of Cholesterol From the Membranes to Catalyze Aggregation and Amyloid Pathology.
    J Neurochem. 2026;170:e70380.
    PubMed         Abstract available

  26. GIAMBARTOLOMEI GH, Iribarren P, Pasquini LA, Peluffo H, et al
    Microglia at the Forefront: New Insights From the Glial Club South Cone Meeting 2025.
    J Neurochem. 2026;170:e70384.
    PubMed         Abstract available


    J Neurol

  27. MATIAS-GUIU JA, Ortega-Madueno I, Gil-Moreno MJ, Cardenas MC, et al
    Impact of blood p-tau217 testing on diagnosis and diagnostic confidence in cognitive disorders: a real-world clinical study.
    J Neurol. 2026;273:130.
    PubMed         Abstract available

  28. XIONG D, Liu M, Liu Z, Wang J, et al
    Integrating standard and native spaces for radiomics and brain network analysis in Alzheimer's disease diagnosis and prognosis.
    J Neurol. 2026;273:124.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  29. KATISKO K, Aaltonen M, Aho K, Heikkinen S, et al
    Survival and mortality rates in early onset dementia.
    J Neurol Neurosurg Psychiatry. 2026;97:256-262.
    PubMed         Abstract available


    JAMA Intern Med

  30. CHIN NA, Erickson CM, Widera E
    Importance of Function for Alzheimer Diagnosis and Management-More Than Memory.
    JAMA Intern Med. 2026 Feb 9. doi: 10.1001/jamainternmed.2025.7621.
    PubMed        


    Nat Med


  31. Capillary blood sampling for detecting biomarkers of Alzheimer's disease.
    Nat Med. 2026 Feb 11. doi: 10.1038/s41591-026-04216.
    PubMed        


    Neurobiol Dis

  32. RYSKAMP D, Wu L, Wu J, Kim D, et al
    Corrigendum to 'Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor' [Neurobiology of Disease Volume 124 April 2019 Pages 489-504].
    Neurobiol Dis. 2026 Feb 13:107311. doi: 10.1016/j.nbd.2026.107311.
    PubMed        


    Neurochem Res

  33. CHEN P, Li G, Cheng L, Liu Y, et al
    HCG18 is a Potential Pathogenic Factor and Diagnostic Biomarker Alzheimer's Disease.
    Neurochem Res. 2026;51:64.
    PubMed         Abstract available


    Neurology

  34. ZAMMIT AR, Yu L, Poole VN, Kapasi A, et al
    Associations of Lifetime Cognitive Enrichment With Incident Alzheimer Disease Dementia, Cognitive Aging, and Cognitive Resilience.
    Neurology. 2026;106:e214677.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  35. BOSKOVIC P, Shalita R, Gao W, Vernon H, et al
    Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2026;123:e2530977123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum